Nuclear Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Nuclear Antibodies for the detection and characterization of nuclear proteins. Nuclear Antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nuclear proteins are fundamental components in cellular processes such as gene expression, DNA replication, and cell cycle regulation. Maintaining proper nuclear protein function is essential for cellular homeostasis and environmental signal response. Alterations in nuclear protein activity can contribute to various diseases, including cancer, making nuclear protein research crucial for understanding disease mechanisms. Nuclear protein research continues to reveal new insights about cellular regulation and potential therapeutic approaches. Research focusing on nuclear proteins has enhanced our understanding of fundamental biological processes and disease development. Nuclear protein studies have opened new avenues for therapeutic development and diagnostic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing nuclear protein research and contributing to scientific discoveries.